Core Scientific Inc vs KB Financial Group, Inc. — how do they compare? Core Scientific Inc trades at $15.61 (market cap $5.12B), while KB Financial Group, Inc. trades at $121.96 (market cap $44.15B). The key difference: KB Financial Group, Inc. is far larger — about 8.6× Core Scientific Inc's market cap, and KB Financial Group, Inc. pays a 2.65% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and KB Financial Group, Inc. for 33 Days on average.
| CORZ | KB | |
|---|---|---|
Market Cap | $5.12B | $44.15B |
Volume | 9,296,664 | 131,395 |
Sector | Technology | Financials |
52-Week High | $29.16 | $132.88 |
52-Week Low | $13.57 | $77.50 |
Typical Hold Time | 20 Days | 33 Days |
Enterprise Value | $7.65B | $215.53T |
Dividend Yield | — | 2.65% |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.94, down 4.44% today amid bearish technical signals. The stock shows weak fundamentals with a -324.9% net income margin and negative earnings misses in recent quarters. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.46 consensus price target. Recent executive appointments and AI data center expansion plans provide growth catalysts despite current profitability challenges.
The outlook balances strong analyst conviction against fundamental weakness. While the AI infrastructure pivot offers long-term potential, investors face significant execution risks and negative cash flow. The stock trades near support levels with technical indicators suggesting caution, requiring careful monitoring of revenue growth and margin improvement for sustained recovery.
KB Financial Group trades at $124.73, showing minimal daily movement with a slight decline of 0.02%. The stock exhibits neutral technical signals while maintaining strong fundamental performance with consistent earnings beats and improving profitability. Recent quarterly results exceeded expectations, with Q2 2026 EPS of $3.79 beating estimates of $3.51. The company demonstrates solid revenue growth, climbing from $17.77T in 2022 to $21.23T in 2025, with net income margins expanding to 27.47%.
KB presents an attractive value proposition with a P/E of 9.92 and P/B of 0.97, trading below book value. Analyst sentiment is mixed with 33% buy ratings but strong institutional interest. Key risks include banking sector volatility and interest rate sensitivity, while opportunities lie in South Korea's outperforming market and the company's expanding non-banking activities driving fee income growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →